Comparing Antares Pharma (ATRS) and LDR Holding Corp (NASDAQ:LDRH)

LDR Holding Corp (NASDAQ: LDRH) and Antares Pharma (NASDAQ:ATRS) are both medical equipment, supplies & distribution – nec companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and target prices for LDR Holding Corp and Antares Pharma, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LDR Holding Corp 0 0 0 0 N/A
Antares Pharma 0 0 3 1 3.25

Antares Pharma has a consensus price target of $3.95, suggesting a potential upside of 114.67%. Given Antares Pharma’s higher possible upside, analysts plainly believe Antares Pharma is more favorable than LDR Holding Corp.


This table compares LDR Holding Corp and Antares Pharma’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LDR Holding Corp -18.02% -16.37% -13.65%
Antares Pharma -32.06% -43.05% -24.14%

Earnings and Valuation

This table compares LDR Holding Corp and Antares Pharma’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
LDR Holding Corp N/A N/A N/A ($0.71) -52.08
Antares Pharma $52.22 million 5.52 -$24.33 million ($0.11) -16.73

LDR Holding Corp has higher revenue, but lower earnings than Antares Pharma. LDR Holding Corp is trading at a lower price-to-earnings ratio than Antares Pharma, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

37.0% of Antares Pharma shares are owned by institutional investors. 11.6% of Antares Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


Antares Pharma beats LDR Holding Corp on 7 of the 10 factors compared between the two stocks.

About LDR Holding Corp

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company’s traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.

About Antares Pharma

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company’s subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

Receive News & Ratings for LDR Holding Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LDR Holding Corp and related companies with's FREE daily email newsletter.

Leave a Reply